Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Quality of life in young men after radical prostatectomy

Abstract

Urinary and sexual function and bother are important outcomes following radical prostatectomy (RP). Since urinary and sexual function are age-related, post-operative bother may vary by age. This study explores the disease-specific quality-of-life outcomes in young men compared with older men undergoing RP. Using CaPSURE data, we identified men who underwent RP and completed the UCLA Prostate Cancer Index (PCI) before and 1-year post-RP. Men were stratified by age (<55 years, 55–64, 65). Multivariate regression models were created: a linear model for predictors of PCI scores and a logistic model for predictors of severe declines in PCI domains. Younger men scored significantly better than older men in urinary function (P=0.04), urinary bother (P=0.02) and sexual function (P<0.0001) 1-year post-RP. Severe declines in urinary bother (odds ratio (OR)=1.54, 1.01–2.35) and sexual function (OR=3.20, 1.97–5.19) were more common in men 65 years. Men with relationships had less urinary bother (P=0.03) and were less likely to experience severe worsening of urinary bother (OR=0.32, 0.17–0.60) while having a greater risk of severe worsening of sexual bother (OR=2.74, 1.28–5.89). The use of sexual aids was associated with worse sexual bother (P<0.0001) and greater risk of severe worsening of sexual bother (OR=2.29, 1.54–3.30). Baseline PCI scores were independent predictors in all models. One year after RP, younger men (age<55) have similar, or better, urinary and sexual function and bother. Baseline scores are strongly associated with post-RP scores and severity of declines. Current relationships and use of sexual aids have significant roles in post-RP bother.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Incidence – SEER 9 Regs Public-Use, Nov 2004 Sub (1973–2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission.

  2. Khan MA, Han M, Partin AW, Epstein JI, Walsh PC . Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology 2003; 62: 86.

    Article  PubMed  Google Scholar 

  3. Twiss C, Slova D, Lepor H . Outcomes for men younger than 50 years undergoing radical prostatectomy. Urology 2005; 66: 141.

    Article  PubMed  Google Scholar 

  4. Varkarakis J, Pinggera GM, Sebe P, Berger A, Bartsch G, Horninger W . Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program. Urology 2004; 63: 337.

    Article  PubMed  Google Scholar 

  5. Jonler M, Moon T, Brannan W, Stone NN, Heisey D, Bruskewitz RC . The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995; 75: 651.

    Article  CAS  PubMed  Google Scholar 

  6. Gwede CK, Pow-Sang J, Seigne J, Heysek R, Helal M, Shade K et al. Treatment decision-making strategies and influences in patients with localized prostate carcinoma. Cancer 2005; 104: 1381.

    Article  PubMed  Google Scholar 

  7. Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E et al. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol 2002; 20: 55.

    Article  PubMed  Google Scholar 

  8. Eastham JA, Kattan MW, Rogers E, Goad JR, Ohori M, Boone TB et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol 1996; 156: 1707.

    Article  CAS  PubMed  Google Scholar 

  9. Wei JT, Dunn RL, Marcovich R, Montie JE, Sanda MG . Prospective assessment of patient reported urinary continence after radical prostatectomy. J Urol 2000; 164: 744.

    Article  CAS  PubMed  Google Scholar 

  10. Karakiewicz PI, Tanguay S, Kattan MW, Elhilali MM, Aprikian AG . Erectile and urinary dysfunction after radical prostatectomy for prostate cancer in Quebec: a population-based study of 2415 men. Eur Urol 2004; 46: 188.

    Article  PubMed  Google Scholar 

  11. Stanford JL, Feng Z, Hamilton AS, Gilliland FD, Stephenson RA, Eley JW et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 2000; 283: 354.

    Article  CAS  PubMed  Google Scholar 

  12. Lubeck DP, Litwin MS, Henning JM, Carroll PR . Measurement of health-related quality of life in men with prostate cancer: the CaPSURE database. Qual Life Res 1997; 6: 385.

    Article  CAS  PubMed  Google Scholar 

  13. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969.

    Article  CAS  Google Scholar 

  14. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH . The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care 1998; 36: 1002.

    Article  CAS  PubMed  Google Scholar 

  15. Jaeschke R, Singer J, Guyatt GH . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407.

    Article  CAS  Google Scholar 

  16. Stucki G, Daltroy L, Katz JN, Johannesson M, Liang MH . Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol 1996; 49: 711.

    Article  CAS  PubMed  Google Scholar 

  17. Norman GR, Sloan JA, Wyrwich KW . Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582.

    Google Scholar 

  18. Hu JC, Elkin EP, Pasta DJ, Lubeck DP, Kattan MW, Carroll PR et al. Predicting quality of life after radical prostatectomy: results from CaPSURE. J Urol 2004; 171: 703.

    Article  PubMed  Google Scholar 

  19. Litwin MS, Flanders SC, Pasta DJ, Stoddard ML, Lubeck DP, Henning JM . Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE, Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1999; 54: 503.

    Article  CAS  PubMed  Google Scholar 

  20. Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J Urol 2005; 173: 1701.

    Article  PubMed  Google Scholar 

  21. Phillips C, Gray RE, Fitch MI, Labrecque M, Fergus K, Klotz L . Early postsurgery experience of prostate cancer patients and spouses. Cancer Pract 2000; 8: 165.

    Article  CAS  PubMed  Google Scholar 

  22. Maliski SL, Heilemann MV, McCorkle R . Mastery of postprostatectomy incontinence and impotence: his work, her work, our work. Oncol Nurs Forum 2001; 28: 985.

    CAS  PubMed  Google Scholar 

  23. Gore JL, Krupski T, Kwan L, Maliski S, Litwin MS . Status influences quality of life in low-income, uninsured men with prostate cancer. Cancer 2005; 104: 191.

    Article  PubMed  Google Scholar 

  24. Boehmer U, Clark JA . About prostate cancer between men and their wives. J Fam Pract 2001; 50: 226.

    CAS  PubMed  Google Scholar 

  25. Litwin MS, Pasta DJ, Yu J, Stoddard ML, Flanders SC . Urinary function and bother after radical prostatectomy or radiation for prostate cancer: a longitudinal, multivariate quality of life analysis from the Cancer of the Prostate Strategic Urologic Research Endeavor. J Urol 2000; 164: 1973.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The current CaPSURE(tm) Investigators are as follows: Peter R Carroll, MD (University of California, San Francisco, CA); James S Cochran, MD (Urology Clinics of North Texas, Dallas, TX); Christopher J Kane, MD (Veterans Administration Medical Center, San Francisco, CA); Donald P Finnerty, MD (PAPP Clinic, Newnan, GA); Eugene V Kramolowsky, MD (The Virginia Urology Center, Richmond, VA); Robert M Segaul, MD (Urology Associates of West Broward, Sunrise, FL); Paul Sieber, MD (Urological Associates of Lancaster, Lancaster, PA); Stanley A Brosman, MD (Pacific Urology Institute, Santa Monica, CA); Lynn W Conrad, MD (The Conrad Pearson Clinic, Germantown, TN); Ronald A Chee-Awai, MD (Urologic Institute of New Orleans, Marrero, LA); Michael Flanagan, MD (Urology Specialists, PC, Waterbury, CT); Jeffrey K Cohen, MD (Triangle Urology Group, Pittsburgh, PA); Jerrold Sharkey, MD (Urology Health Center, New Port Richey, FL); Thomas W Coleman, MD (Bay Urology Services, Mobile, AL); Elliott C Silbar, MD (Clinic of Urology, SC, Milwaukee, WI); Paul S Ray, DO (John H Stroger Hospital of Cook County, Chicago, IL); David Noyes, MD (Berkshire Urological Associates, PC, Pittsfield, MA); Mohammed Mostafavi, MD (Urology Group of Western NewEngland, Springfield, MA); Louis Keeler, III, MD (Delaware Valley Urology, LLC-Voorhees, Voorhees, NJ); James Gottesman, MD (Seattle Urological, Seattle, WA); Bhupendra M Tolia, MD (Associated Advanced Adult & Pediatric Urology, Bronx, NY); Patrick P Daily, MD (Mississippi Urology, Jackson, MS); Glen Wells, MD (Alabama Urology, Birmingham, AL); Richard J Kahnoski, MD (Michigan Medical, PC Urology, Grand Rapids, MI); Sheldon J Freedman, MD (Las Vegas, NV); Randil Clark, MD (North Idaho Urology, Coeur D'Alene, ID); Daniel W Lin, MD (Veterans Administration Puget Sound HCS, Seattle, WA); Mark Austenfeld, MD (Kansas City Urology Care, Kansas City, MO); Henri P Lanctin, MD (Adult & Pediatric Urology, Sartell, MN); J Brantley Thrasher, MD (University of Kansas, Adult Urology and Urologic Oncology, Kansas City, KS); David W Bowyer, MD (Snake River Urology, Twin Falls, ID). Former CaPSURE investigators are as follows: John Forrest, MD (1995–99, Urologic Specialists of Oklahoma, Tulsa, OK); William Schmeid, MD (1995–99, Metro Urology, Jeffersonville, IN); Glen Brunk, MD (1995–99, Urology of Indiana, Indianapolis, IN); Jay Young, MD (1995–2001, South Orange County Medical Research Center, Laguna Woods, CA); Gary Katz, MD (1996–2000, Medical College of Virginia and Veterans Administration Medical Center, Richmond, VA); Stacy J Childs, MD (1999–2000, Cheyenne Urological, Cheyenne, WY); Kevin Tomera, MD (1999–2001, Alaska Urological Associates, Anchorage, AK); Clayton Hudnall, MD (1995–2002, Urology San Antonio Research, San Antonio, TX); David Penson, MD, MPH (2000–2003, Veterans Administration Puget Sound HCS, Seattle, WA); W Lamar Weems, MD (1996–2005, Mississippi Urology, Jackson, MS); Joseph N Macaluso, Jr, MD (1995–2005, Urologic Institute of New Orleans, Gretna, LA). This work was supported by TAP Pharmaceutical Products Inc.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to J L Wright.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wright, J., Lin, D., Cowan, J. et al. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis 11, 67–73 (2008). https://doi.org/10.1038/sj.pcan.4500980

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.pcan.4500980

Keywords

This article is cited by

Search

Quick links